CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Net Cash Flow Growth by Quarter and Year

Boston Scientific's Net Cash Flow results by quarter and year




BSX Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -77.00 629.00 9.00 -287.00
III Quarter September 513.00 39.00 -739.00 266.00
II Quarter June -143.00 -71.00 645.00 1,316.00
I Quarter March -363.00 -1,639.00 258.00 93.00
FY   -70.00 -1,042.00 173.00 1,388.00



BSX Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Boston Scientific Corporation in the fourth quarter 2023 recorded net cash outflow of $ -77.00 millions.

According to the results reported in the fourth quarter 2023, Boston Scientific Corporation achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Boston Scientific Corporation' s Net Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




BSX Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 6888.89 % - -
III Quarter September 1215.38 % - - -
II Quarter June - - -50.99 % -
I Quarter March - - 177.42 % -
FY   - - -87.54 % -

Financial Statements
Boston Scientific's fourth quarter 2023 Net Cash Flow $ -77.00 millions BSX's Income Statement
Boston Scientific's fourth quarter 2022 Net Cash Flow $ 629.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Net Cash Flow Growth >>


BSX Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 1512.82 % - -
III Quarter September - - - -79.79 %
II Quarter June - - 150 % 1315.05 %
I Quarter March - - - -
FY (Year on Year)   - - -87.54 % -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Boston Scientific's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSX's IV. Quarter Q/Q Net Cash Flow Comment
Recent net cash outflow of -77.00 millions by Boston Scientific Corporation look even less good compare to the net cash outflow 513.00 millions in the previous quarter.

Within Medical Equipment & Supplies industry Boston Scientific Corporation achieved highest sequential Net Cash Flow growth. While Boston Scientific's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSX's IV. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -77.00 millions by Boston Scientific Corporation look even worse if you take a look at 513.00 millions in the third quarter.

Within Medical Equipment & Supplies industry Boston Scientific Corporation achieved highest sequential Net Cash Flow growth. While Boston Scientific's Net Cash Flow growth quarter on quarter, overall rank is .


Boston Scientific's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -70.00 $ 636.00 $ 162.00 $ 234.00 $ -1,042.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - 292.59 % -30.77 % - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # # 2308




Cumulative Net Cash Flow growth Comment


Boston Scientific Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
3600 %
-20.34 %
-702.31 %
(Dec. 30, 2014)  

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 12
S&P 500 # 160
Cumulative Net Cash Flow growth Comment


Boston Scientific Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
3600 %
-20.34 %
-702.31 %
(Dec. 30, 2014)  


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 12
S&P 500 # 160




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BSX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BSX's Competitors
Net Cash Flow Growth for Boston Scientific's Suppliers
Net Cash Flow Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Novartis Ag-39.41%$ -39.413 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Altair International Corp -52.34%$ -52.344 millions
Atricure Inc -59.98%$ -59.983 millions
Aurinia Pharmaceuticals Inc -69.48%$ -69.483 millions
Zoetis Inc -73.28%$ -73.277 millions
Kazia Therapeutics Limited-73.32%$ -73.317 millions
Avantor Inc -75.25%$ -75.252 millions
Pluri Inc -76.34%$ -76.339 millions
Replimune Group Inc -81.59%$ -81.589 millions
Catalent Inc -87.58%$ -87.578 millions
Summit Therapeutics Inc -90.96%$ -90.955 millions
Prestige Consumer Healthcare Inc -91.92%$ -91.921 millions
Clearmind Medicine Inc -96.34%$ -96.345 millions
Resmed Inc -97.51%$ -97.508 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com